EFNS guidelines for the molecular diagnosis of neurogenetic disorders: Motoneuron, peripheral nerve and muscle disorders

European Journal of Neurology

Volumn 18, Issue 2, 2011, Pages 207-217

  Burgunder, J M ^a   Schols L ^b   Baets, J ^c,d,e   Andersen, P ^f   Gasser, T ^g   Szolnoki, Z ^h   Fontaine, B ⁱ   Van Broeckhoven, C ^d,e   Di Donato, S ^j   De Jonghe, P ^c,d,e   Lynch, T ^k   Mariotti, C ^j   Spinazzola, A ^j   Tabrizi, S J ^l   Tallaksen, C ^m   Zeviani, M ^j   Harbo, H F ^m   Finsterer, J ⁿ  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^e UNIVERSITY OF ANTWERP   (Belgium)

^f UMEÅ UNIVERSITY   (Sweden)

^g GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^h Pandy County Hospital   (Hungary)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j DEPARTMENT OF NEUROSURGERY   (Italy)

^k BEAUMONT HOSPITAL   (Ireland)

^l NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^m ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

ⁿ DANUBE UNIVERSITY KREMS   (Austria)

more..

Author keywords

Amyotrophic lateral sclerosis; EFNS task force; Molecular diagnosis; Myopathy; Neurogenetics; Polyneuropathy; Spinal muscular atrophy

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; DUCHENNE MUSCULAR DYSTROPHY; FAMILIAL DISEASE; GENETIC DISORDER; GENETIC SCREENING; HEREDITARY MOTOR SENSORY NEUROPATHY; INFORMATION PROCESSING; KENNEDY DISEASE; MEDICAL DECISION MAKING; MOLECULAR DIAGNOSIS; MYOPATHY; MYOTONIC DYSTROPHY; NEUROLOGIC DISEASE; NEUROPATHY; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY;

EID: 78751491533     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03069.x     Document Type: Article

References (23)

1. Gasser T, Dichgans M, Finsterer J, et al. EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. First of two parts. Eur J Neurol 2001; 8: 299-314.
2. Gasser T, Dichgans M, Finsterer J, et al. EFNS Task Force on Molecular Diagnosis of Neurologic Disorders: guidelines for the molecular diagnosis of inherited neurologic diseases. Second of two parts. Eur J Neurol 2001; 8: 407-424.
3. Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces--revised recommendations 2004. Eur J Neurol 2004; 11: 577-581.
4. Schymick JC, Talbot K, Traynor BJ. Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2007; 16(No. 2): R233-R242.
5. Andersen PM, Borasio GD, Dengler R, et al. Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group. Amyotroph Lateral Scler 2007; 8: 195-213.
6. Valdmanis PN, Rouleau GA. Genetics of familial amyotrophic lateral sclerosis. Neurology 2008; 70: 144-152.
7. Kaindl AM, Guenther UP, Rudnik-Schoneborn S, et al. Spinal muscular atrophy with respiratory distress type 1 (SMARD1). J Child Neurol 2008; 23: 199-204.
8. Chahin N, Klein C, Mandrekar J, Sorenson E. Natural history of spinal-bulbar muscular atrophy. Neurology 2008; 70: 1967-1971.
9. Martyn CN, Hughes RA. Epidemiology of peripheral neuropathy. J Neurol Neurosurg Psychiatry 1997; 62: 310-318.
10. Niemann A, Berger P, Suter U. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8: 217-242.
11. Szigeti K, Nelis E, Lupski JR. Molecular diagnostics of Charcot-Marie-Tooth disease and related peripheral neuropathies. Neuromolecular Med 2006; 8: 243-254.
12. Dubourg O, Azzedine H, Verny C, et al. Autosomal-recessive forms of demyelinating Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8: 75-86.
13. Pareyson D, Scaioli V, Laura M. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8: 3-22.
14. Kleopa KA, Scherer SS. Molecular genetics of X-linked Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8: 107-122.
15. Verhoeven K, Claeys KG, Zuchner S, et al. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Brain 2006; 129: 2093-2102.
16. Irobi J, Dierick I, Jordanova A, Claeys KG, De Jonghe P, Timmerman V. Unraveling the genetics of distal hereditary motor neuronopathies. Neuromolecular Med 2006; 8: 131-146.
17. Dierick I, Baets J, Irobi J, et al. Relative contribution of mutations in genes for autosomal dominant distal hereditary motor neuropathies: a genotype-phenotype correlation study. Brain 2008; 131: 1217-1227.
18. Auer-Grumbach M, Mauko B, Auer-Grumbach P, Pieber TR. Molecular genetics of hereditary sensory neuropathies. Neuromolecular Med 2006; 8: 147-158.
19. Rotthier A, Baets J, De Vriendt E, et al. Genes for hereditary sensory and autonomic neuropathies: a genotype-phenotype correlation. Brain 2009; 132: 2699-2711.
20. Chance PF. Inherited focal, episodic neuropathies: hereditary neuropathy with liability to pressure palsies and hereditary neuralgic amyotrophy. Neuromolecular Med 2006; 8: 159-174.
21. Okizuka Y, Takeshima Y, Awano H, Zhang Z, Yagi M, Matsuo M. Small mutations detected by multiplex ligation-dependent probe amplification of the dystrophin gene. Genet Test Mol Biomarkers 2009; 13: 427-431.
22. Kissel JT. Facioscapulohumeral dystrophy. Semin Neurol 1999; 19: 35-43.
23. Peat RA, Smith JM, Compton AG, et al. Diagnosis and etiology of congenital muscular dystrophy. Neurology 2008; 71: 312-321.